company background image
BIT logo

Biotron ASX:BIT Stock Report

Last Price

AU$0.019

Market Cap

AU$17.1m

7D

2.6%

1Y

-81.4%

Updated

13 Nov, 2024

Data

Company Financials

BIT Stock Overview

A biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia.

BIT fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health1/6
Dividends0/6

Biotron Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Biotron
Historical stock prices
Current Share PriceAU$0.019
52 Week HighAU$0.12
52 Week LowAU$0.016
Beta-0.64
11 Month Change-7.14%
3 Month Change-27.78%
1 Year Change-81.43%
33 Year Change-61.00%
5 Year Change-68.55%
Change since IPO-95.62%

Recent News & Updates

Here's Why We're Not Too Worried About Biotron's (ASX:BIT) Cash Burn Situation

Feb 27
Here's Why We're Not Too Worried About Biotron's (ASX:BIT) Cash Burn Situation

We Think Biotron (ASX:BIT) Can Afford To Drive Business Growth

Oct 20
We Think Biotron (ASX:BIT) Can Afford To Drive Business Growth

Recent updates

Here's Why We're Not Too Worried About Biotron's (ASX:BIT) Cash Burn Situation

Feb 27
Here's Why We're Not Too Worried About Biotron's (ASX:BIT) Cash Burn Situation

We Think Biotron (ASX:BIT) Can Afford To Drive Business Growth

Oct 20
We Think Biotron (ASX:BIT) Can Afford To Drive Business Growth

We're Not Worried About Biotron's (ASX:BIT) Cash Burn

Jul 06
We're Not Worried About Biotron's (ASX:BIT) Cash Burn

Will Biotron (ASX:BIT) Spend Its Cash Wisely?

Jan 18
Will Biotron (ASX:BIT) Spend Its Cash Wisely?

Will Biotron (ASX:BIT) Spend Its Cash Wisely?

Jul 06
Will Biotron (ASX:BIT) Spend Its Cash Wisely?

Here's Why We're Watching Biotron's (ASX:BIT) Cash Burn Situation

Mar 17
Here's Why We're Watching Biotron's (ASX:BIT) Cash Burn Situation

Here's Why We're Not Too Worried About Biotron's (ASX:BIT) Cash Burn Situation

Nov 27
Here's Why We're Not Too Worried About Biotron's (ASX:BIT) Cash Burn Situation

Biotron (ASX:BIT) Is In A Good Position To Deliver On Growth Plans

May 26
Biotron (ASX:BIT) Is In A Good Position To Deliver On Growth Plans

We're Not Very Worried About Biotron's (ASX:BIT) Cash Burn Rate

Feb 10
We're Not Very Worried About Biotron's (ASX:BIT) Cash Burn Rate

What Can We Conclude About Biotron's (ASX:BIT) CEO Pay?

Dec 19
What Can We Conclude About Biotron's (ASX:BIT) CEO Pay?

Shareholder Returns

BITAU BiotechsAU Market
7D2.6%1.4%1.5%
1Y-81.4%16.9%17.3%

Return vs Industry: BIT underperformed the Australian Biotechs industry which returned 16.9% over the past year.

Return vs Market: BIT underperformed the Australian Market which returned 17.3% over the past year.

Price Volatility

Is BIT's price volatile compared to industry and market?
BIT volatility
BIT Average Weekly Movement16.6%
Biotechs Industry Average Movement10.1%
Market Average Movement8.5%
10% most volatile stocks in AU Market17.4%
10% least volatile stocks in AU Market3.5%

Stable Share Price: BIT's share price has been volatile over the past 3 months compared to the Australian market.

Volatility Over Time: BIT's weekly volatility (17%) has been stable over the past year, but is still higher than 75% of Australian stocks.

About the Company

FoundedEmployeesCEOWebsite
1999n/aMichelle Millerwww.biotron.com.au

Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company’s lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. Biotron Limited was incorporated in 1999 and is based in Sydney, Australia.

Biotron Limited Fundamentals Summary

How do Biotron's earnings and revenue compare to its market cap?
BIT fundamental statistics
Market capAU$17.14m
Earnings (TTM)-AU$3.44m
Revenue (TTM)AU$1.65m

10.7x

P/S Ratio

-5.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BIT income statement (TTM)
RevenueAU$1.65m
Cost of RevenueAU$0
Gross ProfitAU$1.65m
Other ExpensesAU$5.08m
Earnings-AU$3.44m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.0038
Gross Margin100.00%
Net Profit Margin-208.89%
Debt/Equity Ratio0%

How did BIT perform over the long term?

See historical performance and comparison